Secular trends in opioid prescribing in the USA by Pezalla EJ, Rosen D, Erensen JG, Haddox JD, Mayne TJ

Get full text

Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer. by Janssen, S, Jakobsen, C, Rosen, D, Ricklis, R, Reineke, U, Christensen, S, Lilja, H, Denmeade, SR

Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug. by Janssen, S, Rosen, D, Ricklis, R, Dionne, C, Lilja, H, Christensen, S, Isaacs, J, Denmeade, SR

Synthesis and use of cell-permeant cyclic ADP-ribose. by Rosen, D, Bloor-Young, D, Squires, J, Parkesh, R, Waters, G, Vasudevan, SR, Lewis, A, Churchill, G

Hypertension in pregnancy as an early sex-specific risk factor for cardiovascular diseases: evidence and awareness by Dolina G. Gencheva, Fedya P. Nikolov, Ekaterina H. Uchikova, Krasimira A. Hristova, Rosen D. Mihaylov, Blagovesta G. Pencheva

Get full text

High-sensitivity CRP levels in women with gestational hypertension, preeclampsia and in normotensive pregnant women and its correlations by Dolina G. Gencheva, Fedya P. Nikolov, Ekaterina H. Uchikova, Rosen D. Mihaylov, Blagovesta G. Pencheva, Katerina I. Ivanova

Get full text

Cell-permeant NAADP: a novel chemical tool enabling the study of Ca2+ signalling in intact cells. by Parkesh, R, Lewis, A, Aley, P, Arredouani, A, Rossi, S, Tavares, R, Vasudevan, SR, Rosen, D, Galione, A, Dowden, J, Churchill, G

Analogues of the nicotinic acid adenine dinucleotide phosphate (NAADP) antagonist Ned-19 indicate two binding sites on the NAADP receptor. by Rosen, D, Lewis, A, Mizote, A, Thomas, J, Aley, P, Vasudevan, SR, Parkesh, R, Galione, A, Izumi, M, Ganesan, A, Churchill, G

Identification of a chemical probe for NAADP by virtual screening. by Naylor, E, Arredouani, A, Vasudevan, SR, Lewis, A, Parkesh, R, Mizote, A, Rosen, D, Thomas, J, Izumi, M, Ganesan, A, Galione, A, Churchill, G